Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy

AUTOR(ES)

Bordet, Thierry

FONTE

American Society for Clinical Investigation

RESUMO

Cardiotrophin-1 (CT-1), an IL-6–related cytokine, causes hypertrophy of cardiac myocytes and has pleiotropic effects on various other cell types, including motoneurons. Here, we analyzed systemic CT-1 effects in progressive motor neuronopathy (pmn) mice that suffer from progressive motoneuronal degeneration, muscle paralysis, and premature death. Administration of an adenoviral CT-1 vector to newborn pmn mice leads to sustained CT-1 expression in the injected muscles and bloodstream, prolonged survival of animals, and improved motor functions. CT-1–treated pmn mice showed a significantly reduced degeneration of facial motoneuron cytons and phrenic nerve myelinated axons. The terminal innervation of skeletal muscle, grossly disturbed in untreated pmn mice, was almost completely preserved in CT-1–treated pmn mice. The remarkable neuroprotection conferred by CT-1 might become clinically relevant if CT-1 side effects, including cardiotoxicity, could be circumvented by a more targeted delivery of this cytokine to the nervous system.

Documentos Relacionados

• Cardiotrophin-1 Maintains the Undifferentiated State in Skeletal Myoblasts*
• Adenoviral-mediated gene transfer in lymphocytes
• Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.
• Paraneoplastic motor neuronopathy and malignant acanthosis nigricans
• Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice